MP
IRWD icon

MFN Partners’s Ironwood Pharmaceuticals IRWD Stock Holding History

MFN Partners’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-3,370,000
Closed -$34M – 17
2020
Q1 		$34M Sell
3,370,000
-3,069,541
-48% -$36.1M 4.5% 8
2019
Q4 		$85.7M Hold
6,439,541
– – 17.66% 3
2019
Q3 		$55.3M Buy
6,439,541
+1,500,000
+30% +$14.6M 8.26% 5
2019
Q2 		$54M Sell
4,939,541
-958,271
-16% -$10.7M 8.58% 4
2019
Q1 		$66.8M Hold
5,897,812
– – 10.78% 4
2018
Q4 		$51.2M Buy
+5,897,812
New +$67.7M 8.68% 3

Other funds holding IRWD

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

MFN Partners's IRWD Position: Q2 2020 in Review

MFN Partners sold out of Ironwood Pharmaceuticals (IRWD) in Q2 2020, closing a stake of 3,370,000 shares — an estimated $34M sold.

MFN Partners first reported a position in IRWD in Q4 2018 and held it in 6 quarters. The position peaked at $85.7M in Q4 2019. 202 funds tracked by Wall St. Rank hold IRWD as of Q2 2020.

  • MFN Partners reported no remaining Ironwood Pharmaceuticals position as of Q2 2020 after selling out during the quarter.
  • MFN Partners sold 3,370,000 Ironwood Pharmaceuticals shares in Q2 2020, an estimated $34M.
  • MFN Partners first reported a position in Ironwood Pharmaceuticals in Q4 2018 and held it in 6 quarters.
  • MFN Partners's Ironwood Pharmaceuticals position peaked at $85.7M in Q4 2019.
  • 202 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2020.

Based on MFN Partners's 13F filing for Q2 2020, filed 13 Aug 2020.